Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1987 Nov 15;248(1):61–67. doi: 10.1042/bj2480061

Structure and lipid distribution of polyenoic very-long-chain fatty acids in the brain of peroxisome-deficient patients (Zellweger syndrome).

P Sharp 1, A Poulos 1, A Fellenberg 1, D Johnson 1
PMCID: PMC1148500  PMID: 3435449

Abstract

The polyenoic fatty acids with carbon chain lengths from 26 to 38 (very-long-chain fatty acids, VLCFA) previously detected in abnormal amounts in Zellweger syndrome brain have been shown to be n-6 derivatives and therefore probably derived by chain elongation of shorter-chain n-6 fatty acids such as linoleic acid and arachidonic acid. Polyenoic VLCFA are also present in Zellweger syndrome liver, but this tissue differs significantly from brain in that the saturated and mono-unsaturated derivatives are the major VLCFA. Zellweger syndrome brain polyenoic VLCFA are present in the neutral lipids predominantly in cholesterol esters, with smaller amounts in the non-esterified fatty acid and triacylglycerol fractions. These fatty acids are barely detectable in any of the major phospholipids, but are present in significant amounts in an unidentified minor phospholipid. The polyenoic VLCFA composition of this lipid differs markedly from that observed for all other lipids, as it contains high proportions of pentaenoic and hexaenoic fatty acids with 34, 36 and 38 carbon atoms. A polar lipid with the chromatographic properties in normal brain contains similar fatty acids. It is postulated that the polyenoic VLCFA may play an important role in normal brain and accumulate in Zellweger syndrome brain because of a deficiency in the peroxisomal beta-oxidation pathway, although a possible peroxisomal role in the control of carbon-chain elongation cannot be discounted.

Full text

PDF
61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bridges R. B., Coniglio J. G. The biosynthesis of delta-9,12,15,18-tetracosatetraenoic and of delta-6,9,12,15,18-tetracosapentaenoic acids by rat testes. J Biol Chem. 1970 Jan 10;245(1):46–49. [PubMed] [Google Scholar]
  2. Brown F. R., 3rd, McAdams A. J., Cummins J. W., Konkol R., Singh I., Moser A. B., Moser H. W. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J. 1982 Dec;151(6):344–351. [PubMed] [Google Scholar]
  3. Danks D. M., Tippett P., Adams C., Campbell P. Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. J Pediatr. 1975 Mar;86(3):382–387. doi: 10.1016/s0022-3476(75)80967-x. [DOI] [PubMed] [Google Scholar]
  4. Gibson R. A., Kneebone G. M. Fatty acid composition of human colostrum and mature breast milk. Am J Clin Nutr. 1981 Feb;34(2):252–257. doi: 10.1093/ajcn/34.2.252. [DOI] [PubMed] [Google Scholar]
  5. Goldfischer S., Moore C. L., Johnson A. B., Spiro A. J., Valsamis M. P., Wisniewski H. K., Ritch R. H., Norton W. T., Rapin I., Gartner L. M. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 1973 Oct 5;182(4107):62–64. doi: 10.1126/science.182.4107.62. [DOI] [PubMed] [Google Scholar]
  6. Grogan W. M., Huth E. G. Biosynthesis of long-chain polyenoic acids from arachidonic acid in cultures of enriched spermatocytes and spermatids from mouse testis. Lipids. 1983 Apr;18(4):275–284. doi: 10.1007/BF02534702. [DOI] [PubMed] [Google Scholar]
  7. Heymans H. S., vd Bosch H., Schutgens R. B., Tegelaers W. H., Walther J. U., Müller-Höcker J., Borst P. Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome. Eur J Pediatr. 1984 Apr;142(1):10–15. doi: 10.1007/BF00442582. [DOI] [PubMed] [Google Scholar]
  8. Hiltunen J. K., Kärki T., Hassinen I. E., Osmundsen H. beta-Oxidation of polyunsaturated fatty acids by rat liver peroxisomes. A role for 2,4-dienoyl-coenzyme A reductase in peroxisomal beta-oxidation. J Biol Chem. 1986 Dec 15;261(35):16484–16493. [PubMed] [Google Scholar]
  9. Igarashi M., Schaumburg H. H., Powers J., Kishmoto Y., Kolodny E., Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J Neurochem. 1976 Apr;26(4):851–860. doi: 10.1111/j.1471-4159.1976.tb04462.x. [DOI] [PubMed] [Google Scholar]
  10. KIYASU J. Y., KENNEDY E. P. The enzymatic synthesis of plasmalogens. J Biol Chem. 1960 Sep;235:2590–2594. [PubMed] [Google Scholar]
  11. Kelley R. I. Review: the cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects. Am J Med Genet. 1983 Dec;16(4):503–517. doi: 10.1002/ajmg.1320160409. [DOI] [PubMed] [Google Scholar]
  12. Moser A. E., Singh I., Brown F. R., 3rd, Solish G. I., Kelley R. I., Benke P. J., Moser H. W. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. N Engl J Med. 1984 May 3;310(18):1141–1146. doi: 10.1056/NEJM198405033101802. [DOI] [PubMed] [Google Scholar]
  13. Moser H. W., Moser A. B., Kawamura N., Murphy J., Suzuki K., Schaumburg H., Kishimoto Y. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol. 1980 Jun;7(6):542–549. doi: 10.1002/ana.410070607. [DOI] [PubMed] [Google Scholar]
  14. Moser H. W., Moser A. E., Singh I., O'Neill B. P. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy. Ann Neurol. 1984 Dec;16(6):628–641. doi: 10.1002/ana.410160603. [DOI] [PubMed] [Google Scholar]
  15. Naughton J. M. Supply of polyenoic fatty acids to the mammalian brain: the ease of conversion of the short-chain essential fatty acids to their longer chain polyunsaturated metabolites in liver, brain, placenta and blood. Int J Biochem. 1981;13(1):21–32. doi: 10.1016/0020-711x(81)90132-4. [DOI] [PubMed] [Google Scholar]
  16. Owens K. A two-dimensional thin-layer chromatographic procedure for the estimation of plasmalogens. Biochem J. 1966 Aug;100(2):354–361. doi: 10.1042/bj1000354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Poulos A., Sharp P., Fellenberg A. J., Danks D. M. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum Genet. 1985;70(2):172–177. doi: 10.1007/BF00273077. [DOI] [PubMed] [Google Scholar]
  18. Poulos A., Sharp P., Johnson D., White I., Fellenberg A. The occurrence of polyenoic fatty acids with greater than 22 carbon atoms in mammalian spermatozoa. Biochem J. 1986 Dec 15;240(3):891–895. doi: 10.1042/bj2400891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Poulos A., Sharp P. Plasma and skin fibroblast C26 fatty acids in infantile Refsum's disease. Neurology. 1984 Dec;34(12):1606–1609. doi: 10.1212/wnl.34.12.1606. [DOI] [PubMed] [Google Scholar]
  20. Poulos A., Sharp P., Singh H., Johnson D., Fellenberg A., Pollard A. Detection of a homologous series of C26-C38 polyenoic fatty acids in the brain of patients without peroxisomes (Zellweger's syndrome). Biochem J. 1986 Apr 15;235(2):607–610. doi: 10.1042/bj2350607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Poulos A., Sharp P., Whiting M. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome? Clin Genet. 1984 Dec;26(6):579–586. doi: 10.1111/j.1399-0004.1984.tb01107.x. [DOI] [PubMed] [Google Scholar]
  22. Poulos A., Singh H., Paton B., Sharp P., Derwas N. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants. Clin Genet. 1986 May;29(5):397–408. doi: 10.1111/j.1399-0004.1986.tb00511.x. [DOI] [PubMed] [Google Scholar]
  23. Rosenthal M. D., Hill J. R. Human vascular endothelial cells synthesize and release 24- and 26-carbon polyunsaturated fatty acids. Biochim Biophys Acta. 1984 Sep 12;795(2):171–178. doi: 10.1016/0005-2760(84)90063-8. [DOI] [PubMed] [Google Scholar]
  24. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
  25. Schutgens R. B., Romeyn G. J., Wanders R. J., van den Bosch H., Schrakamp G., Heymans H. S. Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome. Biochem Biophys Res Commun. 1984 Apr 16;120(1):179–184. doi: 10.1016/0006-291x(84)91430-x. [DOI] [PubMed] [Google Scholar]
  26. Singh H., Derwas N., Poulos A. Beta-oxidation of very-long-chain fatty acids and their coenzyme A derivatives by human skin fibroblasts. Arch Biochem Biophys. 1987 May 1;254(2):526–533. doi: 10.1016/0003-9861(87)90133-0. [DOI] [PubMed] [Google Scholar]
  27. Singh I., Moser A. E., Goldfischer S., Moser H. W. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4203–4207. doi: 10.1073/pnas.81.13.4203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Solish G. I., Moser H. W., Ringer L. D., Moser A. E., Tiffany C., Schutta E. The prenatal diagnosis of the cerebro-hepato-renal syndrome of Zellweger. Prenat Diagn. 1985 Jan-Feb;5(1):27–34. doi: 10.1002/pd.1970050106. [DOI] [PubMed] [Google Scholar]
  29. Svennerholm L., Ställberg-Stenhagen S. Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age. J Lipid Res. 1968 Mar;9(2):215–225. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES